Membranous nephropathy: thinking through the therapeutic options

New insights into immune mechanisms underlying response to Rituximab in patients with membranous nephropathy: A prospective study and a review of the literature

(2016) D. Roccatello et al.   AUTOIMMUNITY REVIEWS

Detection of cases of progressive multifocal leukoencephalopathy associated with new biologicals and targeted cancer therapies from the FDA’s adverse event reporting system

(2016) Dennis W. Raisch et al.   Expert Opinion On Drug Safety

Tacrolimus combined with corticosteroids versus Modified Ponticelli regimen in treatment of idiopathic membranous nephropathy: Randomized control trial

(2016) Raja Ramachandran et al.   NEPHROLOGY

Long-term outcomes of persistent disease and relapse in primary membranous nephropathy

(2016) Durga A.K. Kanigicherla et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

A Mechanism for Cancer-Associated Membranous Nephropathy

(2016) Elion Hoxha et al.   NEW ENGLAND JOURNAL OF MEDICINE

Regional Variability of Lifestyle Factors and Hypertension with Prediabetes and Newly Diagnosed Type 2 Diabetes Mellitus: The Population-Based KORA-F4 and SHIP-TREND Studies in Germany

(2016) Doris Stöckl et al.   PLoS One

Anti-Phospholipase A2Receptor Antibodies in Recurrent Membranous Nephropathy

(2015) A. Kattah et al.   AMERICAN JOURNAL OF TRANSPLANTATION

A new rescue regimen with plasma exchange and rituximab in high-risk membranous glomerulonephritis

(2015) Janina Müller-Deile et al.   EUROPEAN JOURNAL OF CLINICAL INVESTIGATION

Efficacy and safety of tacrolimus vs. cyclophosphamide for idiopathic membranous nephropathy: A meta-analysis of Chinese adults

(2015) Zhen-qiong Li et al.   Journal of Huazhong University of Science and Technology-Medical Sciences

Pathophysiological advances in membranous nephropathy: time for a shift in patient's care

(2015) Pierre Ronco et al.   LANCET

Prophylaxis and Treatment of Pneumocystis jiroveci Pneumonia in Lymphoma Patients Subjected to Rituximab-Contained Therapy: A Systemic Review and Meta-Analysis

(2015) Xuqin Jiang et al.   PLoS One

Comparison of tripterygium wilfordii multiglycosides and tacrolimus in the treatment of idiopathic membranous nephropathy: a prospective cohort study

(2015) Shanshan Liu et al.   BMC Nephrology

Synthetic ACTH in High Risk Patients with Idiopathic Membranous Nephropathy: A Prospective, Open Label Cohort Study

(2015) Anne-Els van de Logt et al.   PLoS One

Prognostic value of the dynamics of M-type phospholipase A2 receptor antibody titers in patients with idiopathic membranous nephropathy treated with two different immunosuppression regimens

(2014) Alfonso Segarra Medrano et al.   BIOMARKERS

The influences of larger physical constitutions including obesity on the amount of urine protein excretion in primary glomerulonephritis: research of the Japan Renal Biopsy Registry

(2014) Yuriko Yonekura et al.   Clinical and Experimental Nephrology

Cancer Risk after Cyclophosphamide Treatment in Idiopathic Membranous Nephropathy

(2014) J. A. J. G. van den Brand et al.   Clinical Journal of the American Society of Nephrology

Association of Anti-PLA2R Antibodies with Outcomes after Immunosuppressive Therapy in Idiopathic Membranous Nephropathy

(2014) A. P. Bech et al.   Clinical Journal of the American Society of Nephrology

Bortezomib therapy for nephrotic syndrome due to idiopathic membranous nephropathy

(2014) Choli Hartono et al.   JOURNAL OF NEPHROLOGY

Phospholipase A2 Receptor Autoantibodies and Clinical Outcome in Patients with Primary Membranous Nephropathy

(2014) E. Hoxha et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

A pilot study to determine the dose and effectiveness of adrenocorticotrophic hormone (H.P. Acthar(R) Gel) in nephrotic syndrome due to idiopathic membranous nephropathy

(2014) M. A. Hladunewich et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Thrombospondin Type-1 Domain-Containing 7A in Idiopathic Membranous Nephropathy

(2014) Nicola M. Tomas et al.   NEW ENGLAND JOURNAL OF MEDICINE

Long-term follow-up of patients who received repeat-dose rituximab as maintenance therapy for ANCA-associated vasculitis

(2014) Federico Alberici et al.   RHEUMATOLOGY

Long-Term Outcomes in Idiopathic Membranous Nephropathy Using a Restrictive Treatment Strategy

(2013) J. A. J. G. van den Brand et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Anti-PLA2R antibodies measured by ELISA predict long-term outcome in a prevalent population of patients with idiopathic membranous nephropathy

(2013) Durga Kanigicherla et al.   KIDNEY INTERNATIONAL

Immunosuppression for progressive membranous nephropathy: a UK randomised controlled trial

(2013) Andrew Howman et al.   LANCET

Rituximab in Idiopathic Membranous Nephropathy

(2012) P. Ruggenenti et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Enhanced expression of the M-type phospholipase A2 receptor in glomeruli correlates with serum receptor antibodies in primary membranous nephropathy

(2012) Elion Hoxha et al.   KIDNEY INTERNATIONAL

Determination of primary versus secondary membranous glomerulopathy utilizing phospholipase A2 receptor staining in renal biopsies

(2012) Christopher P Larsen et al.   MODERN PATHOLOGY

Historical Aspects of Proteinuria

(2011) Daniel C. Cattran   ADVANCES IN CHRONIC KIDNEY DISEASE

Have We Changed the Outcome in Membranous Nephropathy? A Propensity Study on the Role of Immunosuppressive Therapy

(2011) D. C. Cattran et al.   Clinical Journal of the American Society of Nephrology

Idiopathic membranous nephropathy and nephrotic syndrome: outcome in the era of evidence-based therapy

(2011) E. P. McQuarrie et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Mycophenolate versus Azathioprine as Maintenance Therapy for Lupus Nephritis

(2011) Mary Anne Dooley et al.   NEW ENGLAND JOURNAL OF MEDICINE

Risk HLA-DQA1 and PLA2R1 Alleles in Idiopathic Membranous Nephropathy

(2011) Horia C. Stanescu et al.   NEW ENGLAND JOURNAL OF MEDICINE

Tacrolimus Combined With Corticosteroids in Treatment of Nephrotic Idiopathic Membranous Nephropathy: A Multicenter Randomized Controlled Trial

(2010) Min Chen et al.   AMERICAN JOURNAL OF THE MEDICAL SCIENCES

Rituximab Therapy in Idiopathic Membranous Nephropathy: A 2-Year Study

(2010) F. C. Fervenza et al.   Clinical Journal of the American Society of Nephrology

Spontaneous Remission of Nephrotic Syndrome in Idiopathic Membranous Nephropathy

(2010) N. Polanco et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

The incidence of primary glomerulonephritis worldwide: a systematic review of the literature

(2010) A. McGrogan et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

The Natural History of the Non-Nephrotic Membranous Nephropathy Patient

(2009) M. A. Hladunewich et al.   Clinical Journal of the American Society of Nephrology

M-Type Phospholipase A2Receptor as Target Antigen in Idiopathic Membranous Nephropathy

(2009) Laurence H. Beck et al.   NEW ENGLAND JOURNAL OF MEDICINE

Mycophenolate Mofetil Monotherapy in Membranous Nephropathy: A 1-Year Randomized Controlled Trial

(2008) Bertrand Dussol et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

Introduction of a cyclophosphamide-based treatment strategy and the risk of ESRD in patients with idiopathic membranous nephropathy: A nationwide survey in the Netherlands

(2008) J. M. Hofstra et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Remission of proteinuria in primary glomerulonephritis: we know the goal but do we know the price?

(2008) David Philibert et al.   Nature clinical practice. Nephrology

Rituximab treatment of idiopathic membranous nephropathy

(2007) F.C. Fervenza et al.   KIDNEY INTERNATIONAL